Quantcast

Latest AMD Stories

2014-05-08 09:24:07

Researchers have found that, contrary to previous clinical trial findings, monthly injections to counteract age-related macular degeneration (AMD) may not be necessary. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. The investigators used a strategy called "treat and extend" to conduct the study, in which the frequency of office visits and injections were tailored to each patient's...

2014-04-24 08:35:50

Renowned ophthalmic expert to provide critical guidance to MacuLogix HUMMELSTOWN, Pa., April 24, 2013 /PRNewswire/ -- MacuLogix, Inc., a pioneer in the early detection and tracking of age-related macular degeneration (AMD), today announced the appointment of Joan W. Miller, MD FARVO as a Clinical Advisor. Dr. Miller will provide MacuLogix with guidance on the development and commercialization of the Company's AdaptDx®, an advanced dark adaptometer used by eye care physicians to...

2014-04-22 12:30:18

- Proceeds will Further Strengthen Avalanche's Proprietary BioFactoryTM Platform and Advance Clinical Program in Wet Age-Related Macular Degeneration - MENLO PARK, Calif., April 22, 2014 /PRNewswire/ -- Avalanche Biotechnologies, Inc, a leader in the development of innovative gene therapies for serious eye diseases such as wet age-related macular degeneration (AMD), today announced the successful completion of a $55 million Series B financing. New investors were led by Venrock, and...

2014-04-16 08:32:56

William Greene, MD, Appointed Chief Executive Officer SOUTH SAN FRANCISCO, Calif. and ATLANTA, April 16, 2014 /PRNewswire/ -- Iconic Therapeutics, Inc., a biotechnology company focused on developing therapeutics for serious eye disorders, announced today that it has successfully completed a $20 million Series B-1 equity financing from new investors MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures. Iconic's lead clinical-stage program is a novel recombinant human chimeric...

2014-04-15 23:16:08

When people of any age are confined to the house due to mobility & health issues, they generally have limited opportunities to socialize with those outside the home. The new Adult Mobility Device can provided them with a comfortable, adjustable ride, while protecting them from harsh weather conditions or excessive sun. Los Angeles, California (PRWEB) April 14, 2014 The adjustable Adult Mobility Device has a modern, high-tech design and is fully adjustable. The AMD has large wheels in...

2014-04-08 23:23:45

AMD Radeon™ R9 295X2 Graphics Card Engineered for Ultimate Performance San Jose, CA (PRWEB) April 08, 2014 Asetek®, the world’s leading supplier of computer liquid cooling solutions, today announced that its liquid cooling technology will be used to cool AMD’s latest flagship graphics card. The new AMD Radeon™ R9 295X2 is the world’s fastest graphics card. Boasting 8 gigabytes of memory and over 11 teraflops of computing power, the AMD Radeon™ R9 295X2 graphics card is...

2014-04-03 11:04:31

Scientists at Trinity College Dublin have made a major breakthrough with important implications for sufferers of the eye disease Age-Related Macular Degeneration (AMD), which can cause central blindness in sufferers. The scientists found that a component of the immune system, 'IL-18', acts as a guardian of eyesight by suppressing the production of damaging blood vessels behind the retina at the back of the eye. In addition, in pre-clinical models, it was shown that 'IL-18' can be...

2014-03-24 23:02:12

By Integrating AMD Media SDK with AMF-DEM Library, Splashtop Can Deliver Remote 3D Experience at Low Latency and High Framerate San Jose, CA (PRWEB) March 24, 2014 Splashtop Inc., the worldwide leader in cross-device computing, announced optimization of Splashtop Streamer on select AMD discrete GPUs and APUs. Users can now enjoy remote HD video streaming, 3D professional graphics, and gaming experience, with super low latency.     “Splashtop turns every PC with...

2014-03-24 12:34:08

DALLAS, March 24, 2014 /PRNewswire/ -- According to the new market research report "Micro Server IC Market by Processor (Intel, ARM, AMD), IC's (Analog, Digital), Applications (Media Storage, Data Center, Cloud Computing, Analytics) & by Geography (N.America, Europe, APAC, ROW) - Global Forecasts and Analysis to 2013 - 2018", published by MarketsandMarkets, the global Micro Server IC Market is projected to cross $3.1 Billion by 2018, growing at a very high CAGR from 2013...

2014-03-24 12:30:49

LONDON, March 24, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Analysis of the US Retinal Therapeutics Market Improvements in Administration and Efficacy Drive GrowthSince the introduction of Lucentis in 2006, vascular endothelial growth factor (VEGF) antagonists have become the clear choice in treatment for age related macular degeneration, diabetic macular edema, and retinal vein occlusion due to their high efficacy and safety. This research...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.